Search research articles
Contact Us
Filters
Showing results (141-150 of 224) with videos related to
Page
of 23
Sort By:
Immunogenetics
|
January 1, 1992
Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198
P J Dyson, C de Smet, A M Knight, et al.
European Journal of Immunology
|
February 1, 1995
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
F Lehmann, M Marchand, P Hainaut, et al.
International Journal of Cancer
|
March 15, 1987
Production of stable cytolytic T-cell clones directed against autologous human melanoma
M Hérin, C Lemoine, P Weynants, et al.
Cancer Research
|
March 4, 1998
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
S Lucas, C De Smet, K C Arden, et al.
Atherosclerosis
|
March 21, 2001
Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes
F Van Leuven, E Thiry, M Lambrechts, et al.
Cancer Immunology, Immunotherapy : CII
|
February 28, 2001
Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes
A Van Pel, E De Plaen, M T Duffour, et al.
International Immunology
|
October 1, 1991
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides
J L Maryanski, P Romero, A Van Pel, et al.
The Journal of Experimental Medicine
|
August 1, 1993
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
V Brichard, A Van Pel, T Wölfel, et al.
European Journal of Immunology
|
March 1, 1994
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
T Wölfel, A Van Pel, V Brichard, et al.
International Journal of Antimicrobial Agents
|
September 1, 1995
A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections
R de Gier, A Karperien, K Bouter, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 224) with videos related to
Sort By:
Page
of 23
Immunogenetics
|
January 1, 1992
Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198
P J Dyson, C de Smet, A M Knight, et al.
European Journal of Immunology
|
February 1, 1995
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
F Lehmann, M Marchand, P Hainaut, et al.
International Journal of Cancer
|
March 15, 1987
Production of stable cytolytic T-cell clones directed against autologous human melanoma
M Hérin, C Lemoine, P Weynants, et al.
Cancer Research
|
March 4, 1998
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
S Lucas, C De Smet, K C Arden, et al.
Atherosclerosis
|
March 21, 2001
Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes
F Van Leuven, E Thiry, M Lambrechts, et al.
Cancer Immunology, Immunotherapy : CII
|
February 28, 2001
Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes
A Van Pel, E De Plaen, M T Duffour, et al.
International Immunology
|
October 1, 1991
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides
J L Maryanski, P Romero, A Van Pel, et al.
The Journal of Experimental Medicine
|
August 1, 1993
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
V Brichard, A Van Pel, T Wölfel, et al.
European Journal of Immunology
|
March 1, 1994
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
T Wölfel, A Van Pel, V Brichard, et al.
International Journal of Antimicrobial Agents
|
September 1, 1995
A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections
R de Gier, A Karperien, K Bouter, et al.
Page
of 23